Exploration of Memory Disorders and Novel Treatment Methods, Highlighting Transcranial Magnetic Stimulation Therapy
Transcranial Magnetic Stimulation (TMS) therapy, traditionally used for the treatment of clinical depression and treatment-resistant depression, is now being explored for a variety of mental health and neurological conditions, particularly those involving cognitive impairment and memory disorders.
This innovative approach is gaining traction in the mental health community, with researchers and clinicians asking about its potential applications for other mental health conditions. One platform leading the charge is based in Northern California, where Dr. Joshua Kuluva, director of neurological services, is at the helm.
Dr. Kuluva, who has taught at prestigious institutions such as NYU School of Medicine, UCSF/UC Berkeley Joint Medical Program, and Touro University College of Osteopathic Medicine, shares the company's applied optimism and result-driven efforts. He leads the platform's efforts in further developing TMS services for those suffering from mild cognitive impairment, mild dementia, central neuropathic pain, and post-stroke rehabilitation.
The platform is one of the first to use TMS treatment for memory disorders, pushing the boundaries of what TMS technology can do. It offers TMS therapy to individuals with mild cognitive impairment, defined as an intermediary stage between normal aging and mild dementia. Those diagnosed with mild cognitive impairment are at a significant risk of progressing to mild dementia, and severe cognitive impairment can lead to a loss of independence and the inability to interpret the significance of something or someone.
The success of TMS therapy is measured by the relief it provides from symptoms of clinical depression. However, in the context of cognitive impairment, the benefits are observed by mental health professionals at the platform's facilities. A course of TMS treatment for cognitive impairment consists of 25 sessions over a period of 7 weeks, with each session lasting approximately 25 minutes.
The application of TMS therapy for memory disorders involves cognitive exercise while undergoing treatment. It has shown promise in chronic pain management, indicating its broader utility in overlapping neuropsychiatric symptoms beyond depression alone. Advanced EEG-guided personalized TMS approaches are being developed to optimize stimulation for improved network-level brain function, which is relevant for treating cognitive dysfunction in psychiatric and potentially memory-related disorders.
The emerging applications of TMS therapy are grounded in its ability to modulate neuroplasticity and brain network functioning, which is crucial for memory and cognitive improvement. These applications include stroke rehabilitation, multiple sclerosis, chronic pain syndromes with neuropsychiatric comorbidities, and cognitive rehabilitation more broadly by modulating attention and memory networks.
The costs of treating cognitive impairment can be astronomical, with those suffering from cognitive impairment reporting more than three times as many hospital visits compared to people who are hospitalized for other conditions. As California's baby boomer population is expected to double the number of Californians suffering from Alzheimer's within the next 20 years, and the cognitively-impaired populations among California's Latino and Asian-American populations are set to triple over the same period, the need for effective and affordable treatment options is more pressing than ever.
If you live in northern California and believe you may be experiencing cognitive impairment, please contact the platform for help. The platform employs doctors whose goals align with the company's mission, and they are dedicated to providing the best possible care for their patients.
References: [1] Advances in TMS for Neurological Treatment, Number Analytics, 2025. [2] Differential Effects of rTMS on Mood and Pain Symptoms, Eur. J. Pain, 2025. [3] Personalized EEG-guided brain stimulation targetting, PMC, 2025.
- Transcranial Magnetic Stimulation (TMS) therapy, initially used for treatment-resistant depression and clinical depression, is now being explored for various mental health conditions and neurological disorders, particularly those involving cognitive impairment and memory disorders.
- The success of TMS therapy in cognitive impairment is measured by the relief it provides from symptoms related to memory and cognitive functioning, as observed by mental health professionals.
- As California's baby boomer population is expected to double the number of Californians suffering from Alzheimer's within the next 20 years, and the cognitively-impaired populations among California's Latino and Asian-American populations are set to triple over the same period, the need for effective and affordable treatment options, such as TMS therapy, is more pressing than ever.
